Free tool
FAERS Monitor: Technetium Tc-99m Medronate Kit
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018107 or its brand name (Technetium Tc-99m Medronate Kit, Technetium Tc-99m Medronate Kit). Reports on generic versions are filed under their own applications.
Reports
5
Serious
2
40% of reports
Hospitalization
1
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pruritus2
- chills1
- dysphagia1
- erythema1
- eye oedema1
- eye pain1
- hypersensitivity1
- hypoaesthesia1
- mucosal inflammation1
- palpitations1
- rash1
- stomatitis1
- throat tightness1
- visual impairment1
- vomiting1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,154 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| eye oedema | 1 | 1715.9 | 297.1 | 428 |
| mucosal inflammation | 1 | 160.7 | 27.8 | 39 |
| throat tightness | 1 | 155.5 | 26.9 | 38 |
| eye pain | 1 | 74.6 | 12.9 | 18 |
| stomatitis | 1 | 69.4 | 12.0 | 16 |
| dysphagia | 1 | 44.3 | 7.7 | 10 |
| palpitations | 1 | 35.9 | 6.2 | 8 |
| chills | 1 | 35.9 | 6.2 | 8 |
| visual impairment | 1 | 33.9 | 5.9 | 8 |
| hypoaesthesia | 1 | 28.1 | 4.9 | 6 |
| hypersensitivity | 1 | 22.7 | 3.9 | 5 |
| pruritus | 2 | 21.9 | 7.5 | 22 |
| erythema | 1 | 20.5 | 3.5 | 4 |
| rash | 1 | 9.7 | 1.7 | 2 |
| vomiting | 1 | 8.9 | 1.5 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.